Dynamics of sequencing of cyclin-dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone-receptor positive, human epidermal growth factor 2-negative advancedbreast cancer

Saved in:
Bibliographic Details
Main Authors: Amol Patel, T VSGK Tilak, Vineet G Gupta, Atul Batra, Prashant Mehta, Purvish Parikh, Hemant Malhotra
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=2;spage=311;epage=313;aulast=
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849402479210397696
author Amol Patel
T VSGK Tilak
Vineet G Gupta
Atul Batra
Prashant Mehta
Purvish Parikh
Hemant Malhotra
author_facet Amol Patel
T VSGK Tilak
Vineet G Gupta
Atul Batra
Prashant Mehta
Purvish Parikh
Hemant Malhotra
author_sort Amol Patel
collection DOAJ
format Article
id doaj-art-8383d82559604894b77b8aef74bb2b07
institution Kabale University
issn 0971-5851
0975-2129
language English
publishDate 2019-01-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series Indian Journal of Medical and Paediatric Oncology
spelling doaj-art-8383d82559604894b77b8aef74bb2b072025-08-20T03:37:31ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58510975-21292019-01-0140231131310.4103/ijmpo.ijmpo_111_19Dynamics of sequencing of cyclin-dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone-receptor positive, human epidermal growth factor 2-negative advancedbreast cancerAmol PatelT VSGK TilakVineet G GuptaAtul BatraPrashant MehtaPurvish ParikhHemant Malhotrahttp://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=2;spage=311;epage=313;aulast=
spellingShingle Amol Patel
T VSGK Tilak
Vineet G Gupta
Atul Batra
Prashant Mehta
Purvish Parikh
Hemant Malhotra
Dynamics of sequencing of cyclin-dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone-receptor positive, human epidermal growth factor 2-negative advancedbreast cancer
Indian Journal of Medical and Paediatric Oncology
title Dynamics of sequencing of cyclin-dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone-receptor positive, human epidermal growth factor 2-negative advancedbreast cancer
title_full Dynamics of sequencing of cyclin-dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone-receptor positive, human epidermal growth factor 2-negative advancedbreast cancer
title_fullStr Dynamics of sequencing of cyclin-dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone-receptor positive, human epidermal growth factor 2-negative advancedbreast cancer
title_full_unstemmed Dynamics of sequencing of cyclin-dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone-receptor positive, human epidermal growth factor 2-negative advancedbreast cancer
title_short Dynamics of sequencing of cyclin-dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone-receptor positive, human epidermal growth factor 2-negative advancedbreast cancer
title_sort dynamics of sequencing of cyclin dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone receptor positive human epidermal growth factor 2 negative advancedbreast cancer
url http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=2;spage=311;epage=313;aulast=
work_keys_str_mv AT amolpatel dynamicsofsequencingofcyclindependentkinaseinhibitorsandcostexpenditureanalysisinthemanagementofmetastatichormonereceptorpositivehumanepidermalgrowthfactor2negativeadvancedbreastcancer
AT tvsgktilak dynamicsofsequencingofcyclindependentkinaseinhibitorsandcostexpenditureanalysisinthemanagementofmetastatichormonereceptorpositivehumanepidermalgrowthfactor2negativeadvancedbreastcancer
AT vineetggupta dynamicsofsequencingofcyclindependentkinaseinhibitorsandcostexpenditureanalysisinthemanagementofmetastatichormonereceptorpositivehumanepidermalgrowthfactor2negativeadvancedbreastcancer
AT atulbatra dynamicsofsequencingofcyclindependentkinaseinhibitorsandcostexpenditureanalysisinthemanagementofmetastatichormonereceptorpositivehumanepidermalgrowthfactor2negativeadvancedbreastcancer
AT prashantmehta dynamicsofsequencingofcyclindependentkinaseinhibitorsandcostexpenditureanalysisinthemanagementofmetastatichormonereceptorpositivehumanepidermalgrowthfactor2negativeadvancedbreastcancer
AT purvishparikh dynamicsofsequencingofcyclindependentkinaseinhibitorsandcostexpenditureanalysisinthemanagementofmetastatichormonereceptorpositivehumanepidermalgrowthfactor2negativeadvancedbreastcancer
AT hemantmalhotra dynamicsofsequencingofcyclindependentkinaseinhibitorsandcostexpenditureanalysisinthemanagementofmetastatichormonereceptorpositivehumanepidermalgrowthfactor2negativeadvancedbreastcancer